LUNG Q4 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+23.3% YoY

Gross Profit

$18M74.0% margin

Operating Income

-$13M-56.5% margin

Net Income

-$13M-55.4% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+16.6%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$163M

Total Liabilities

$77M

Stockholders' Equity

$86M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$19M	+23.3%
Gross Profit	$18M	$14M	+23.0%
Operating Income	-$13M	-$14M	+3.6%
Net Income	-$13M	-$14M	+5.1%

Geographic Segments

UNITED STATES

$16M67%

EMEA

$6M26%

Asia Pacific

$2M7%

Other International Geographical Areas

$101,0000%